Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Treatment of pulmonary hypertension with carbonic anhydrase inhibitors

US Patent 8071557 · Granted Dec 6, 2011

Estimated economic value: $10,664,000

Assignee

Inventors

View full patent text on Google Patents →